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Time magazine even managed a
scoop that asserted that Shanghai
had been hit much worse than
health authorities had admitted.
That’s the kind of story only a
reporter with Chinese street
smarts could get. The reporter
seemingly snuck into a hospital
dressed in a white coat and talked
to doctors who mistakenly
assumed the reporter was some
sort of health official. Yet no other
journalist ever confirmed that
report, and the Chinese
government never budged in its
claim that Shanghai was basically
spared. That story hangs today as
a big question mark. Scoop or
miscue? Who’s to say?
When a World Health
Organization team went into the
provinces to look for SARS, a
reporter for the Times of London
followed along in secret. He
staked out the hospital the WHO
team was to visit and noticed that
all the special precautions
demonstrated for the WHO
delegation were not practiced for
other visitors to the hospital. You
don’t need to be a science
reporter to do that story - you just
need an overdeveloped sense of
suspicion, which likely you would
develop by working in China for a
few years.
Still, there was a place for
science reporters. At one news
conference, Laurie Garrett
challenged the Chinese health
officials to explain their
unbelievably low mortality rate.
She pointed out that they were
simply dividing the number of
cases by the number of dead.
That produced a low mortality rate
because it assumed every case
currently alive would survive.
After talking quietly with some
of the international
epidemiologists on the scene, I
finally decided that the Chinese
disease rate reports were
believable (which isn’t quite the
same thing as being truthful). They
fit nicely on an epidemic curve
and accounted correctly for a
significant reporting lag. They
were also consistent with the
sometimes-draconian measures
the government and citizens of
China were taking to stop the
epidemic.
I spent hours arguing with a 
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BBC reporter about whether the
incidence figures were credible or
a tissue of lies. Finally, when the
Beijing government announced
that it was sending children back
to school, the BBC reporter
grudgingly admitted that the
epidemic must really be coming
under control.
Meanwhile, back in New York,
Washington, Los Angeles and
Chicago, science reporters kept
their hand in the SARS story by
telephone conference with the
WHO in Geneva and the Centers
for Disease Control and
Prevention in Atlanta. They missed
seeing the scared look of the cab
driver peering over his mask and
the desperate signs in the empty
restaurants declaring ‘No SARS.’
But we all had a perspective on
SARS, and it added up to one
dramatic story.
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Twelve key scientific nations,
including the US and the UK, and
others in Europe and elsewhere
have joined the International Stem
Cell Forum, which will standardize
research tools, benchmarks and
procedures. This will allow teams
in different countries to compare
results on the characteristics of
the cells and their possible use in
tackling conditions ranging from
diabetes to Parkinson’s.
UK scientists are set to take a
leading role. The project was
established at a meeting chaired
by the Mecical Research Council
lat month. It will be coordinated by
Peter Andrews, head of Sheffield
University’s Centre for Stem Cell
Biology
The MRC has already begun
work on a stem-cell bank for the
various lines of stem cells – each
derived from separate sources
around the world – that will
provide raw material for scientists.
The UK government has pledged
funds for stem-cell research, while
the European Commission
announced this week that it would
provide further resources subject
to strict ethical guidelines.
The work promises a
revolutionary way to repair
diseased and damaged body
tissues. Many scientists believe
that stem cells derived from
embryos have the most potential,
but ethical objections to such
experimentation have been raised.
Sir George Radda, the chief
executive of the MRC, who has
championed stem-cell research in
the UK, said he was pleased with
the speed with which the
mechanisms for global
cooperation – particularly in quality
control, intellectual property rights
and ethics – had been put in place.
`There is a will on everybody’s
part to do this in a coordinated
way. International coordination will
accelerate progress in research,
maximizing health benefits for the
global public,’ he said.
Data gathered by scientists in
the 12 countries will be posted in a
registry of stem-cell lines funded
by the forum. This will allow results
to be compared and stimulate
collaborations.
Two other key activities agreed
by the forum were international
practice on ethical and patenting
issues. These will be collated by
Canada and Australia, which will
report to the forum at its next
meeting in Sweden, in January.
Professor Radda said: `We hope
to map out an ethical landscape.
At the moment, a German
researcher funded by German
funds would be acting illegally if he
took part in research in the UK.’
After the meeting, the European
Commission published proposals
foe ethical guidelines for its
funding of stem-cell research as
part of the Sixth Framework
Programme.
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Researchers across 12 countries are joining forces to coordinate work
on stem cells that aims to streamline experimental approaches.
Nigel Williams reports. 
